5 studies found for:    17765406 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: < 15% risk of + LN;   Radiation: > 15% risk of + LN
2 Recruiting High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer;   Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer
Interventions: Radiation: Brachytherapy;   Radiation: Stereotactic Body Radiation Therapy;   Procedure: Quality-of-life assessment;   Other: Questionnaire administration
3 Recruiting Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: 70 Gy/CGE;   Radiation: 72.5 Gy/CGE
4 Not yet recruiting Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: CF-CRT combined with BT or SBRT boost.;   Radiation: CF-CRT alone;   Drug: Hormonal treatment (neoadjuvant androgen deprivation)
5 Not yet recruiting Prognostic Value of the Levels of CTCs in Peripheral Blood in Patients With Prostate Cancer at High Risk (Clinical Stages IIB-III) Treated Radically With Radiotherapy and Hormone Therapy.
Condition: Patients With High-risk Prostate Cancer
Intervention:

Indicates status has not been verified in more than two years